If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

Share Price is delayed by 15 minutes
Get Live Data
4.20    -0.10 (-2.33%)
Bid:
4.00
Ask:
4.40
Spread: 0.40 (10.00%)
Market Cap: £10.80m
TEK Live PriceLast checked at - London Stock Exchange

Intraday TekCapital Share Chart

Trading Update

21 Nov 2014 07:00

RNS Number : 6313X
Tekcapital plc
21 November 2014
 



21 November2014

 

Tekcapital Plc

 

("Tekcapital", "the Company" or "the Group")

 

 

Trading update

 

- Tekcapital announces strategy to purchase disruptive IP opportunities for future value creation -

 

 

Tekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, is pleased to provide the following update on trading for the year ending 30 November 2014.

 

Tekcapital is making solid progress against many of the strategic objectives set out at the time of the Group's admission to AIM. The Group continues to scale the business and has secured several new clients in the North American market, including three within the Fortune 1000 spanning the automotive, healthcare and food and beverage industries, with negotiations continuing with a number of potential additional customers. As of 20 November 2014, the Group had secured 15 retained clients, which represents growth of over 100 per cent since the Group joined AIM in Q2 2014.

 

The Group has not yet completed any technology transfers and now considersthere to be less predictability on the timing of such revenues than anticipated at the time of the IPO. In light of this, the Directors have been focusing on adding new clients with recurring monthly revenue and implementing a per report, variable costs structure that is scalable while reducing fixed operating costs. This has reduced the Company's monthly fixed costs considerably, as a result of which, while revenue for the year will be significantly lower than anticipated, the loss at an operating level is likely to be broadly in line with market expectations.

 

Through the acquisition of Invention Evaluator, announced on 23 July 2014, the Group has added an additional service for clients seeking to determine the marketability of new technologies they are considering investing in. In the month of October 2014, the Group received paid orders for 89 Invention Evaluator reports. This strong order book compares to 36 reports sold in the month of October 2013 and management anticipates orders for November 2014 to be above the levels in the same month in 2013.

 

To enhance the Group's ability to address new client needs, Dr. Alan Naidoff has recently been appointed as an additional Managing Director of Technology Transfer. Dr. Naidoff was formerly the Director, Discovery Transactions, Business Development & Licensing at Merck Sharp & Dohme Corp.

 

Tekcapital, through the combination of its Innovation Discovery Network ("IDN") and leveraging the knowledge of its Science Advisory Board to evaluate specific IP opportunities, has unrivalled access to a significant number of potentially disruptive technologies. Given this insight and the ability to immediately source and acquire these IP opportunities, Tekcapital will now seek to augment its offering by entering into agreements with universities and research centres to purchase the exclusive licences for certain potentially disruptive Intellectual Property rights. The Group intends to fund these highly selective acquisitions by the issuance of new shares in Tekcapital and, where appropriate, may also satisfy the purchase consideration from existing cash resources.

 

All potential acquisitions will be carefully evaluated and will not utilise a significant portion of the Group's cash balances. The Group anticipates that any acquisition will be of a modest expenditure and will not have a material impact on the Group's cash position over time. Tekcapital will realise value from these technologies by seeking to sell-on the rights to these unique assets to businesses and commercial enterprises.

 

Commenting on the announcement, Dr. Clifford Gross, Executive Chairman of Tekcapital plc, said:

 

"Tekcapital is delivering against the strategy that we set out when we joined AIM earlier this year. Notwithstanding that we have not yet closed our first technology transfer, we have significantly increased our retained customer base and the fact that globally recognisable Fortune 1000 companies are working with us we believe is testament to both the need for our offering and our professionalism. We are currently in contract negotiations with a number of companies in the US, Europe and Asia which we expect to have a significant impact on total client numbers, a key metric for the Company, in future reporting periods. Additionally, the acquisition of Invention Evaluator has expanded our service offering and client base and is already generating top line revenue and profit. We remain confident on the future growth prospects of our unique business and the strategic opportunities before us."

 

For further information please contact:

 

Tekcapital Plc

+44 (0) 1865 261445

Malcolm Groat, Finance Director

mgroat@tekcapital.com

Northland Capital Partners Limited (NOMAD & Broker)

+44 (0) 20 7382 1100

William Vandyk / Lauren Kettle (Corporate Finance)

lkettle@northlandcp.co.uk

John Howes / Alice Lane (Corporate Broking)

Optiva Securities Limited (Co-Broker)

+44 (0) 20 3137 1904

Jeremy King / Vishal Balasingham

jeremy.king@optivasecurities.com

FTI Consulting, LLP

+44 (0) 20 3727 1000

Chris Lane / Emma Appleton / Roger Newby

tekcapital@fticonsulting.com

 

 

Tekcapital plc - The World's Largest University Network for Open Innovation

 

Tekcapital helps clients profit from new, university-developed intellectual properties. With our proprietary discovery search engine, linked to 3,300+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage. Tekcapital plc is listed on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGGGCGUPCPUU
Date   Source Headline
12th May 20257:00 amRNSPortfolio Company Update:Guident Corp Proposed IPO
6th May 20257:00 amRNSPortfolio Company Update - Innovative Eyewear Inc.
28th Apr 20257:00 amRNSPortfolio Company Update - Innovative Eyewear Inc
24th Apr 20257:00 amRNSQ1 2025 Business Update
10th Apr 20257:00 amRNS-RInnovative Eyewear Receives EU Certification
31st Mar 20255:34 pmRNSUnaudited Results to 31 December 2024
20th Mar 20257:00 amRNS$0.35m Contract Win
13th Mar 20257:00 amRNSCorporate Update & 2025 Outlook
17th Feb 20257:00 amRNS2024 Review - Year End Portfolio Update
14th Feb 20251:22 pmRNSNotification of Major Holdings
3rd Feb 20257:00 amRNSOversubscribed Fundraising of £2.3Million
30th Jan 20257:00 amRNS-RInnovative Eyewear announces Key Partnership
22nd Jan 202511:14 amRNSNotification of Major Holdings
21st Jan 20257:00 amRNSGuident Receives Significant New Patent Coverage
17th Jan 20259:13 amRNSPlacing of £0.5 million (c.$0.6m)
15th Jan 20257:00 amRNSGuident Corp. Appointment of Investment Banker
20th Dec 20247:00 amRNSPortfolio Company Update - Guident Ltd
4th Dec 20247:00 amRNSIssue of Shares to Advisers
25th Nov 20249:13 amRNS-RPortfolio Company Update - Innovative Eyewear
20th Nov 20244:26 pmRNSNotification of Major Holdings
20th Nov 20247:00 amRNSCorporate Update
15th Nov 20247:00 amRNSFundraising of £1.0 Million
30th Oct 20247:00 amRNSNew and Follow-on B2B Customer Orders
8th Oct 20247:00 amRNSCorporate Update
2nd Oct 20248:00 amRNSTekcapital Spins out GenIP onto AIM
25th Sep 20247:00 amRNSHalf Year Results
18th Sep 20247:58 amRNSGenIP plc Schedule One
16th Sep 20247:00 amRNSMultiple Placements of Products and B2B Progress
13th Sep 20241:37 pmRNSHolding(s) in Company
29th Aug 20247:00 amRNSPortfolio Company Update Innovative Eyewear Inc
13th Aug 20247:00 amRNSInnovative Eyewear 2nd Q24 Revenue increased 82%
1st Jul 202411:21 amRNSGrant of Share Options
21st Jun 20244:20 pmRNSResults of Annual General Meeting
30th May 20247:00 amRNSPortfolio Company Update - Innovative Eyewear
22nd May 20247:00 amRNSFinal Results year ended 31 December 2023
2nd May 20247:00 amRNSPortfolio Company Update Guident Q1 2024
26th Apr 20247:00 amRNSInnovative Eyewear Canadian Partnership
25th Apr 20247:00 amRNSInnovative Eyewear Patent Filings
18th Apr 20247:00 amRNSInnovative Eyewear Signs Brand Ambassador
17th Apr 20247:00 amRNSInnovative Eyewear Distribution Partnership
9th Apr 20247:00 amRNSPortfolio Company Update : Guident Ltd
5th Apr 20247:00 amRNSPortfolio Company Update : Guident Ltd
28th Mar 202410:20 amRNSNotification of Major Holdings
7th Mar 202411:15 amRNSNotification of Major Holdings
6th Mar 20247:00 amRNSIntellectual Property Update
29th Feb 20247:51 amRNSFundraising of £2.0 million
19th Feb 20247:00 amRNSPortfolio Company Update : Guident Ltd
15th Feb 202410:31 amRNSNotification of Major Holdings
15th Feb 20247:00 amRNSGuident Expands its Strategic Partnership
13th Feb 20242:24 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.